Skip to main
HNGE

HNGE Stock Forecast & Price Target

HNGE Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 35%
Buy 59%
Hold 6%
Sell 0%
Strong Sell 0%

Bulls say

Hinge Health is a leading software platform for virtual physical therapy and has shown strong financial growth in recent quarters. With partnerships with major health plans and PBMs, innovative technology, and potential for meaningful margin expansion, there is a long runway for high growth potential. Additionally, with a focus on diversity and data privacy, the company is well-positioned for sustainability in the long term. Based on our analysis, we have set a PT of $65, reflecting a premium to its peers due to its leading solution in a growing market.

Bears say

Hinge Health is a growing technology platform with strong execution in member engagement and post-enrollment support, leading to impressive yield increases. However, the company's dependence on employee utilization to drive billings growth poses a risk and its valuation may not be justified given the added risk. Additionally, increased competition and shifts in healthcare trends could impact the company's growth and retention.

HNGE has been analyzed by 17 analysts, with a consensus rating of Buy. 35% of analysts recommend a Strong Buy, 59% recommend Buy, 6% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Hinge Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Hinge Health Inc (HNGE) Forecast

Analysts have given HNGE a Buy based on their latest research and market trends.

According to 17 analysts, HNGE has a Buy consensus rating as of May 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $62.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $62.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Hinge Health Inc (HNGE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.